Finland· FI-REL-REL5335

Neodit Retard

A dibenzepin product, registered in Finland by Sandoz Pharma Ag.

ATC N06AA08

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedNeodit RetardATCN06AA08REGISTER NO.FI-REL-REL5335PACKS LISTED0CHECKEDSeptember 27, 2026

The record

At a glance

Fimea (Finland)
Manufacturer
Sandoz Pharma Ag
Country
Finland (FI)
ATC code
N06AA08
ATC class
Dibenzepin
Defined daily dose
0.3 g, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

34 interactions on record for dibenzepin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Dibenzepin · interactions on record

34 records

34 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b2bcd9bc-d21b-4134-a1c6-27d943974bee
GET /v1/drugs/b2bcd9bc-d21b-4134-a1c6-27d943974bee?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "0.3",
  "form": "depottabletti",
  "route": null,
  "ddd_unit": "g",
  "strength": "240 mg",
  "atc_label": "dibentsepiini",
  "ma_number": "5953",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL5335",
  "authorised_at": "1969-12-19"
}

See everything about dibenzepin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.